Health Condition 1: P073- Preterm [premature] newborn [other]
Conditions
Interventions
Control Intervention1: NIL: NIL
Sponsors
Riya Asokan
Eligibility
Inclusion criteria
Inclusion criteria: All inborn neonates with respiratory distress born between 23-34 weeks.
Exclusion criteria
Exclusion criteria: Newborns >34 weeks gestation at birth All out born babies Infants who received surfactant for indications other than RDS (Eg; Pulmonary hemorrhage, Meconium aspiration) Infants with fatal congenital anomalies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the mortality rate of preterm infants who received surfactant with infants who did not receive surfactant. Timepoint: The outcomes will be assessed at the time of discharge / death. (However, all the date are collected retrospectively) | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the following outcomes : The major morbidities (ROP, BPD, IVH) To evaluate the incidence of Type I RDS in preterm neonates less than 34 weeks. The length of NICU stay Duration of invasive / non-invasive ventilation Impact of early versus late surfactant administration (less than 6 hrs and after 6hrs) Timepoint: 3 months | — |
Countries
India
Contacts
Public ContactDr Aswin S Prabhu
Department of neonatology , Amrita Institute Of Medical Sciences
Outcome results
None listed